Sangamo Therapeutics, Inc.
USD0.07
+0.02 (+48.00%)
CEO
Alexander D. Macrae Ch.B
IPO Date
2000-04-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.13
Prev. Close
$0.05
Day Low
$0.06
Day High
$0.13
52W Low
$0.03
52W High
$0.77
Market Cap
$0.03B
Volume
28.50M
| -2.1 |
| 31 Dec 2023 | FY | 100.0% | -146.3% | -311.1% | -156.0% | 0.46 | 1.98 | -0.4 |
| 31 Dec 2022 | FY | 89.1% | -172.8% | -65.2% | -34.2% | 0.15 | 2.69 | -2.5 |
| 31 Dec 2021 | FY | 100.0% | -161.1% | -47.5% | -24.7% | 0.13 | 3.12 | -6.1 |
| 31 Dec 2020 | FY | -52.8% | -102.4% | -24.3% | -12.9% | 0.08 | 4.60 | -17.3 |
| 31 Dec 2019 | FY | -42.5% | -92.9% | -22.0% | -14.9% | 0.10 | 5.80 | -9.9 |
| 31 Dec 2018 | FY | -36.0% | -80.9% | -18.6% | -11.6% | 0.08 | 5.23 | -16.3 |
| 31 Dec 2017 | FY | -79.7% | -149.2% | -29.0% | -19.0% | 0.13 | 5.54 | -23.5 |
| 31 Dec 2016 | FY | -238.4% | -369.6% | -52.6% | -45.4% | 0.03 | 11.25 | -3.0 |
| -0.9 |
| 30 Sept 2025 | Q3 | 100.0% | -6012.0% | -559.5% | -39.4% | 4.07 | 0.88 | -1.5 |
| 30 Jun 2025 | Q2 | 100.0% | -109.2% | -102.0% | -20.5% | 1.20 | 1.05 | -1.7 |
| 31 Mar 2025 | Q1 | 100.0% | -475.3% | -623.7% | -35.5% | 5.07 | 0.76 | -1.2 |
| 31 Dec 2024 | Q4 | 100.0% | -309.8% | -102.7% | -23.0% | 1.34 | 1.13 | -2.3 |
| 30 Sept 2024 | Q3 | 100.0% | 21.6% | 27.3% | 9.6% | 0.71 | 1.35 | 4.2 |
| 30 Jun 2024 | Q2 | 100.0% | -10148.3% | -152.5% | -38.8% | 1.23 | 1.03 | -0.5 |
| 31 Mar 2024 | Q1 | 100.0% | -10205.6% | -86.6% | -38.1% | 0.54 | 1.71 | -0.6 |
| 31 Dec 2023 | Q4 | 100.0% | -2952.7% | -72.7% | -36.5% | 0.46 | 1.98 | -0.4 |